Andrew J. Tebben

Person

New Hope, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Tricyclic heterocyclic compounds useful as inhibitors of TNF
- Patent number 10,308,652
- Issue date Jun 4, 2019
- Bristol-Myers Squibb Company
- Stephen T. Wrobleski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted tricyclic heterocyclic compounds
- Patent number 10,189,840
- Issue date Jan 29, 2019
- Bristol-Myers Squibb Company
- Hai-Yun Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carbazole and tetrahydrocarbazole compounds useful as inhibitors of...
- Patent number 10,023,534
- Issue date Jul 17, 2018
- Bristol-Myers Squibb Company
- Scott Hunter Watterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic benzodiazepine dimers, conjugates thereof, preparation...
- Patent number 9,902,740
- Issue date Feb 27, 2018
- Bristol-Myers Squibb Company
- Yong Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indole carboxamide compounds
- Patent number 9,802,915
- Issue date Oct 31, 2017
- Bristol-Myers Squibb Company
- Qingjie Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGFβR antagonists
- Patent number 9,708,316
- Issue date Jul 18, 2017
- Bristol-Myers Squibb Company
- Brian E. Fink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic benzodiazepine dimers, conjugates thereof, preparation...
- Patent number 9,688,694
- Issue date Jun 27, 2017
- Bristol-Myers Squibb Company
- Yong Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted sulfonamides useful as antiapoptotic Bcl inhibitors
- Patent number 9,346,795
- Issue date May 24, 2016
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzylpyrrolidinone derivatives as modulators of chemokine receptor...
- Patent number 9,040,526
- Issue date May 26, 2015
- Bristol-Myers Squibb Company
- Ian K. Mangion
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nicotinamide compounds useful as kinase modulators
- Patent number 8,586,751
- Issue date Nov 19, 2013
- Bristol-Myers Squibb Company
- George V. De Lucca
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds useful as kinase modulators
- Patent number 8,476,430
- Issue date Jul 2, 2013
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carbazole carboxamide compounds useful as kinase inhibitors
- Patent number 8,362,065
- Issue date Jan 29, 2013
- Bristol-Myers Squibb Company
- Qingjie Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds useful as kinase modulators
- Patent number 8,188,272
- Issue date May 29, 2012
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carbazole carboxamide compounds useful as kinase inhibitors
- Patent number 8,084,620
- Issue date Dec 27, 2011
- Bristol-Myers Squibb Company
- Qingjie Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gamma-lactams as beta-secretase inhibitors
- Patent number 7,557,137
- Issue date Jul 7, 2009
- Bristol-Myers Squibb Company
- Carl P. Decicco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,841,367
- Issue date Jan 11, 2005
- Merck & Co., Inc.
- Richard L. Kendall
- G01 - MEASURING TESTING
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,841,382
- Issue date Jan 11, 2005
- Merck & Co., Inc.
- Richard L. Kendall
- G01 - MEASURING TESTING
Information Patent Grant
Succinoylamino carbocycles and heterocycles as inhibitors of a-&#x0...
- Patent number 6,525,044
- Issue date Feb 25, 2003
- Bristol-Myers Squibb Company
- Richard E Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,359,115
- Issue date Mar 19, 2002
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Angiogenesis inhibitors
- Patent number 6,265,403
- Issue date Jul 24, 2001
- Merck & Co., Inc.
- Mark E. Fraley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,204,011
- Issue date Mar 20, 2001
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER
- Publication number 20230322803
- Publication date Oct 12, 2023
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF Beta RECEPTOR ANTAGONISTS
- Publication number 20190292179
- Publication date Sep 26, 2019
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TNF
- Publication number 20180111937
- Publication date Apr 26, 2018
- Bristol-Myers Squibb Company
- Stephen T. WROBLESKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED TRICYCLIC HETEROCYCLIC COMPOUNDS
- Publication number 20180111936
- Publication date Apr 26, 2018
- Bristol-Myers Squibb Company
- Hai-Yun XIAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC ATROPISOMER COMPOUNDS
- Publication number 20170355673
- Publication date Dec 14, 2017
- Bristol-Myers Squibb Company
- Scott Hunter Watterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, PREPARATION...
- Publication number 20170260205
- Publication date Sep 14, 2017
- Bristol-Myers Squibb Company
- Yong ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLE CARBOXAMIDE COMPOUNDS
- Publication number 20170260160
- Publication date Sep 14, 2017
- Bristol-Myers Squibb Company
- Qingjie Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLE CARBOXAMIDE COMPOUNDS
- Publication number 20170066740
- Publication date Mar 9, 2017
- Bristol-Myers Squibb Company
- Qingjie Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, PREPARATION...
- Publication number 20160376288
- Publication date Dec 29, 2016
- Bristol-Myers Squibb Company
- Yong ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF BETA R ANTAGONISTS
- Publication number 20160176871
- Publication date Jun 23, 2016
- Bristol-Myers Squibb Company
- Brian E. Fink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLE CARBOXAMIDE COMPOUNDS
- Publication number 20160115126
- Publication date Apr 28, 2016
- Qingjie Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS
- Publication number 20140135318
- Publication date May 15, 2014
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZYLPYRROLIDINONE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR...
- Publication number 20120295899
- Publication date Nov 22, 2012
- Bristol -Myers Squibb Company
- Ian K. Mangion
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NICOTINAMIDE COMPOUNDS USEFUL AS KINASE MODULATORS
- Publication number 20120082702
- Publication date Apr 5, 2012
- Bristol -Meyers Squibb Company
- George V. DeLucca
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS
- Publication number 20120058996
- Publication date Mar 8, 2012
- Bristol -Myers Squibb Company
- Qingjie Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS
- Publication number 20110124640
- Publication date May 26, 2011
- Bristol -Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS
- Publication number 20100160303
- Publication date Jun 24, 2010
- Bristol -Myers Squibb Company
- Qingjie Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS
- Publication number 20100105676
- Publication date Apr 29, 2010
- Bristol -Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel gamma-lactams as beta-secretase inhibitors
- Publication number 20070265331
- Publication date Nov 15, 2007
- Carl P. Decicco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human receptor tyrosine kinase, KDR
- Publication number 20030055239
- Publication date Mar 20, 2003
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human receptor tyrosine kinase, KDR
- Publication number 20030032160
- Publication date Feb 13, 2003
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Succinoylamino carbocycles and heterocycles as inhibitors of a-beta...
- Publication number 20020055501
- Publication date May 9, 2002
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY

Andrew J. Tebben

Person

Patents Grantslast 30 patents

Tricyclic heterocyclic compounds useful as inhibitors of TNF

Substituted tricyclic heterocyclic compounds

Carbazole and tetrahydrocarbazole compounds useful as inhibitors of...

Macrocyclic benzodiazepine dimers, conjugates thereof, preparation...

Indole carboxamide compounds

TGFβR antagonists

Macrocyclic benzodiazepine dimers, conjugates thereof, preparation...

Substituted sulfonamides useful as antiapoptotic Bcl inhibitors

Benzylpyrrolidinone derivatives as modulators of chemokine receptor...

Nicotinamide compounds useful as kinase modulators

Fused heterocyclic compounds useful as kinase modulators

Carbazole carboxamide compounds useful as kinase inhibitors

Fused heterocyclic compounds useful as kinase modulators

Carbazole carboxamide compounds useful as kinase inhibitors

Gamma-lactams as beta-secretase inhibitors

Human receptor tyrosine kinase, KDR

Human receptor tyrosine kinase, KDR

Succinoylamino carbocycles and heterocycles as inhibitors of a-&#x0...

Human receptor tyrosine kinase, KDR

Angiogenesis inhibitors

Human receptor tyrosine kinase, KDR

Patents Applicationslast 30 patents

SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER

TGF Beta RECEPTOR ANTAGONISTS

TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TNF

SUBSTITUTED TRICYCLIC HETEROCYCLIC COMPOUNDS

TRICYCLIC ATROPISOMER COMPOUNDS

MACROCYCLIC BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, PREPARATION...

INDOLE CARBOXAMIDE COMPOUNDS

INDOLE CARBOXAMIDE COMPOUNDS

MACROCYCLIC BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, PREPARATION...

TGF BETA R ANTAGONISTS

INDOLE CARBOXAMIDE COMPOUNDS

SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS

BENZYLPYRROLIDINONE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR...

NICOTINAMIDE COMPOUNDS USEFUL AS KINASE MODULATORS

CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS

FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS

CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS

FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS

Novel gamma-lactams as beta-secretase inhibitors

Human receptor tyrosine kinase, KDR

Human receptor tyrosine kinase, KDR

Succinoylamino carbocycles and heterocycles as inhibitors of a-beta...